Top compounds associated with response to DEFB106B


Feature Type Standardized
Nominal ANOVA
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.034 0.4
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA VAF-347 CTRPv2 pan-cancer AAC 0.04 0.4
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.031 0.4
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.027 0.4
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA JW-480 CTRPv2 pan-cancer AAC -0.032 0.4
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
mRNA canertinib CTRPv2 pan-cancer AAC -0.031 0.4
Download CSV